Do analysts rate NGVT or IOSP?

Ingevity currently has a consensus price target of $80.00, suggesting a potential upside of 9.35%. Given Ingevity's stronger consensus rating and higher possible upside, equities analysts clearly believe Ingevity is more favorable than Innospec. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ingevity 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Innospec 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation & earnings, NGVT or IOSP?

Innospec has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ingevity $1.17B 2.18 -$167.10M -$3.55 N/A Innospec $1.79B 1.18 $116.60M $4.59 18.73

Is NGVT or IOSP more profitable?

Innospec has a net margin of 6.38% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Innospec's return on equity. Company Net Margins Return on Equity Return on Assets Ingevity 4.65% 284.70% 10.82% Innospec 6.38% 9.32% 6.79%

Does the media favor NGVT or IOSP?

In the previous week, Ingevity had 17 more articles in the media than Innospec. MarketBeat recorded 21 mentions for Ingevity and 4 mentions for Innospec. Innospec's average media sentiment score of 0.82 beat Ingevity's score of 0.77 indicating that Innospec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ingevity 6 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Innospec 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, AVNT or NGVT?

Avient has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avient $3.26B 1.02 $81.90M $1.72 21.12 Ingevity $1.17B 2.18 -$167.10M -$3.55 N/A

Is AVNT or NGVT more profitable?

Avient has a net margin of 4.81% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Avient's return on equity. Company Net Margins Return on Equity Return on Assets Avient 4.81% 11.11% 4.40% Ingevity 4.65% 284.70% 10.82%

Does the media prefer AVNT or NGVT?

In the previous week, Ingevity had 18 more articles in the media than Avient. MarketBeat recorded 21 mentions for Ingevity and 3 mentions for Avient. Avient's average media sentiment score of 1.07 beat Ingevity's score of 0.77 indicating that Avient is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avient 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ingevity 6 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate SCL or NGVT?

Ingevity has a consensus price target of $80.00, suggesting a potential upside of 9.35%. Given Ingevity's stronger consensus rating and higher probable upside, analysts plainly believe Ingevity is more favorable than Stepan. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stepan 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Ingevity 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Which has preferable valuation & earnings, SCL or NGVT?

Stepan has higher revenue and earnings than Ingevity. Stepan is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Stepan $2.43B 0.60 $46.90M -$0.12 N/A Ingevity $1.17B 2.18 -$167.10M -$3.55 N/A

Is SCL or NGVT more profitable?

Ingevity has a net margin of 4.65% compared to Stepan's net margin of -0.11%. Ingevity's return on equity of 284.70% beat Stepan's return on equity. Company Net Margins Return on Equity Return on Assets Stepan -0.11% 3.90% 2.01% Ingevity 4.65% 284.70% 10.82%

Does the media prefer SCL or NGVT?

In the previous week, Ingevity had 1 more articles in the media than Stepan. MarketBeat recorded 21 mentions for Ingevity and 20 mentions for Stepan. Stepan's average media sentiment score of 0.86 beat Ingevity's score of 0.77 indicating that Stepan is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stepan 6 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Ingevity 6 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, TKR or NGVT?

Timken has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Timken, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Timken $4.58B 2.09 $288.40M $4.40 31.29 Ingevity $1.17B 2.18 -$167.10M -$3.55 N/A

Is TKR or NGVT more profitable?

Timken has a net margin of 6.60% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Timken's return on equity. Company Net Margins Return on Equity Return on Assets Timken 6.60% 11.84% 5.79% Ingevity 4.65% 284.70% 10.82%

Does the media prefer TKR or NGVT?

In the previous week, Ingevity had 10 more articles in the media than Timken. MarketBeat recorded 21 mentions for Ingevity and 11 mentions for Timken. Timken's average media sentiment score of 1.21 beat Ingevity's score of 0.77 indicating that Timken is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Timken 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ingevity 6 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ESI or NGVT?

In the previous week, Element Solutions and Element Solutions both had 21 articles in the media. Element Solutions' average media sentiment score of 1.30 beat Ingevity's score of 0.77 indicating that Element Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Element Solutions 15 Very Positive mention(s) 5 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ingevity 6 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Ingevity (NGVT) Competitors

$73.16 +2.97 (+4.23%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$73.08 -0.08 (-0.11%)

As of 07/31/2026 06:36 PM Eastern

Compare

NGVT vs. IOSP, AVNT, SCL, TKR, and ESI

Should you buy Ingevity stock or one of its competitors? MarketBeat compares Ingevity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ingevity include Innospec (IOSP), Avient (AVNT), Stepan (SCL), Timken (TKR), and Element Solutions (ESI).

How does Ingevity compare to Innospec?

Ingevity (NYSE:NGVT) and Innospec (NASDAQ:IOSP) are both mid-cap materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

Innospec has a net margin of 6.38% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Innospec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ingevity	4.65%	284.70%	10.82%
Innospec	6.38%	9.32%	6.79%

Ingevity has a beta of 1.16, indicating that its share price is 16% more volatile than the broader market. Comparatively, Innospec has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market.

Ingevity currently has a consensus price target of $80.00, suggesting a potential upside of 9.35%. Given Ingevity's stronger consensus rating and higher possible upside, equities analysts clearly believe Ingevity is more favorable than Innospec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Innospec	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

91.6% of Ingevity shares are owned by institutional investors. Comparatively, 96.6% of Innospec shares are owned by institutional investors. 0.9% of Ingevity shares are owned by insiders. Comparatively, 1.5% of Innospec shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Innospec has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ingevity	$1.17B	2.18	-$167.10M	-$3.55	N/A
Innospec	$1.79B	1.18	$116.60M	$4.59	18.73

In the previous week, Ingevity had 17 more articles in the media than Innospec. MarketBeat recorded 21 mentions for Ingevity and 4 mentions for Innospec. Innospec's average media sentiment score of 0.82 beat Ingevity's score of 0.77 indicating that Innospec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ingevity	6 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Innospec	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Ingevity beats Innospec on 9 of the 16 factors compared between the two stocks.

How does Ingevity compare to Avient?

Avient (NYSE:AVNT) and Ingevity (NYSE:NGVT) are both mid-cap materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

Avient has a net margin of 4.81% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Avient's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avient	4.81%	11.11%	4.40%
Ingevity	4.65%	284.70%	10.82%

Avient has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, Ingevity has a beta of 1.16, indicating that its share price is 16% more volatile than the broader market.

Avient has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avient	$3.26B	1.02	$81.90M	$1.72	21.12
Ingevity	$1.17B	2.18	-$167.10M	-$3.55	N/A

In the previous week, Ingevity had 18 more articles in the media than Avient. MarketBeat recorded 21 mentions for Ingevity and 3 mentions for Avient. Avient's average media sentiment score of 1.07 beat Ingevity's score of 0.77 indicating that Avient is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avient	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ingevity	6 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

95.5% of Avient shares are owned by institutional investors. Comparatively, 91.6% of Ingevity shares are owned by institutional investors. 0.9% of Avient shares are owned by company insiders. Comparatively, 0.9% of Ingevity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Avient currently has a consensus target price of $45.71, indicating a potential upside of 25.82%. Ingevity has a consensus target price of $80.00, indicating a potential upside of 9.35%. Given Avient's stronger consensus rating and higher probable upside, research analysts clearly believe Avient is more favorable than Ingevity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avient	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Avient beats Ingevity on 10 of the 16 factors compared between the two stocks.

How does Ingevity compare to Stepan?

Stepan (NYSE:SCL) and Ingevity (NYSE:NGVT) are both materials companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk.

Ingevity has a net margin of 4.65% compared to Stepan's net margin of -0.11%. Ingevity's return on equity of 284.70% beat Stepan's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stepan	-0.11%	3.90%	2.01%
Ingevity	4.65%	284.70%	10.82%

Stepan has higher revenue and earnings than Ingevity. Stepan is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stepan	$2.43B	0.60	$46.90M	-$0.12	N/A
Ingevity	$1.17B	2.18	-$167.10M	-$3.55	N/A

Stepan has a beta of 0.95, indicating that its stock price is 5% less volatile than the broader market. Comparatively, Ingevity has a beta of 1.16, indicating that its stock price is 16% more volatile than the broader market.

Ingevity has a consensus price target of $80.00, suggesting a potential upside of 9.35%. Given Ingevity's stronger consensus rating and higher probable upside, analysts plainly believe Ingevity is more favorable than Stepan.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stepan	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, Ingevity had 1 more articles in the media than Stepan. MarketBeat recorded 21 mentions for Ingevity and 20 mentions for Stepan. Stepan's average media sentiment score of 0.86 beat Ingevity's score of 0.77 indicating that Stepan is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stepan	6 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Ingevity	6 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

82.7% of Stepan shares are owned by institutional investors. Comparatively, 91.6% of Ingevity shares are owned by institutional investors. 6.6% of Stepan shares are owned by insiders. Comparatively, 0.9% of Ingevity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Ingevity beats Stepan on 11 of the 16 factors compared between the two stocks.

How does Ingevity compare to Timken?

Timken (NYSE:TKR) and Ingevity (NYSE:NGVT) are related mid-cap companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

Timken has a net margin of 6.60% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Timken's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Timken	6.60%	11.84%	5.79%
Ingevity	4.65%	284.70%	10.82%

89.1% of Timken shares are owned by institutional investors. Comparatively, 91.6% of Ingevity shares are owned by institutional investors. 8.1% of Timken shares are owned by insiders. Comparatively, 0.9% of Ingevity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Ingevity had 10 more articles in the media than Timken. MarketBeat recorded 21 mentions for Ingevity and 11 mentions for Timken. Timken's average media sentiment score of 1.21 beat Ingevity's score of 0.77 indicating that Timken is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Timken	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ingevity	6 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Timken currently has a consensus target price of $150.00, suggesting a potential upside of 8.94%. Ingevity has a consensus target price of $80.00, suggesting a potential upside of 9.35%. Given Ingevity's higher probable upside, analysts clearly believe Ingevity is more favorable than Timken.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Timken	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Timken has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Timken, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Timken	$4.58B	2.09	$288.40M	$4.40	31.29
Ingevity	$1.17B	2.18	-$167.10M	-$3.55	N/A

Timken has a beta of 1.2, suggesting that its stock price is 20% more volatile than the broader market. Comparatively, Ingevity has a beta of 1.16, suggesting that its stock price is 16% more volatile than the broader market.

Summary

Timken beats Ingevity on 9 of the 16 factors compared between the two stocks.

How does Ingevity compare to Element Solutions?

Element Solutions (NYSE:ESI) and Ingevity (NYSE:NGVT) are both mid-cap materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings and dividends.

In the previous week, Element Solutions and Element Solutions both had 21 articles in the media. Element Solutions' average media sentiment score of 1.30 beat Ingevity's score of 0.77 indicating that Element Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Element Solutions	15 Very Positive mention(s)	5 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ingevity	6 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Element Solutions has a beta of 1.23, indicating that its stock price is 23% more volatile than the broader market. Comparatively, Ingevity has a beta of 1.16, indicating that its stock price is 16% more volatile than the broader market.

Element Solutions has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Element Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Element Solutions	$2.55B	3.50	$190.80M	$0.74	49.59
Ingevity	$1.17B	2.18	-$167.10M	-$3.55	N/A

92.3% of Element Solutions shares are owned by institutional investors. Comparatively, 91.6% of Ingevity shares are owned by institutional investors. 6.2% of Element Solutions shares are owned by insiders. Comparatively, 0.9% of Ingevity shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Element Solutions presently has a consensus target price of $43.50, indicating a potential upside of 18.55%. Ingevity has a consensus target price of $80.00, indicating a potential upside of 9.35%. Given Element Solutions' stronger consensus rating and higher probable upside, research analysts plainly believe Element Solutions is more favorable than Ingevity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Element Solutions	0 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	3 Strong Buy rating(s)	3.00
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Element Solutions has a net margin of 5.67% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Element Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Element Solutions	5.67%	14.88%	7.51%
Ingevity	4.65%	284.70%	10.82%

Summary

Element Solutions beats Ingevity on 13 of the 16 factors compared between the two stocks.

Get Ingevity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NGVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NGVT vs. The Competition

Export

Metric	Ingevity	Chemicals Industry	Materials Sector	NYSE Exchange
Market Cap	$2.44B	$11.30B	$4.64B	$23.71B
Dividend Yield	N/A	2.84%	4.75%	4.20%
P/E Ratio	49.77	20.91	20.04	31.01
Price / Sales	2.18	50.72	4,732.90	13.91
Price / Cash	5.72	15.07	26.49	31.71
Price / Book	54.19	3.35	8.15	4.62
Net Income	-$167.10M	$223.52M	$155.11M	$1.07B
7 Day Performance	-0.16%	0.14%	-0.59%	0.35%
1 Month Performance	0.61%	0.17%	-2.19%	-0.19%
1 Year Performance	80.95%	21.10%	37.96%	19.11%

Ingevity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NGVT Ingevity	1.855 of 5 stars	$73.16 +4.2%	$80.00 +9.3%	+74.8%	$2.44B	$1.17B	49.77	1,500	News Coverage Positive News Earnings Report Analyst Downgrade
IOSP Innospec	3.6743 of 5 stars	$86.23 +0.7%	N/A	+7.6%	$2.12B	$1.78B	18.79	2,450	Positive News Upcoming Earnings
AVNT Avient	4.1282 of 5 stars	$37.19 +2.1%	$45.71 +22.9%	+14.9%	$3.41B	$3.28B	21.64	9,000	Upcoming Earnings
SCL Stepan	2.6388 of 5 stars	$57.73 +0.3%	N/A	+26.3%	$1.31B	$2.33B	N/A	2,328	News Coverage Earnings Report Dividend Announcement Analyst Upgrade
TKR Timken	4.6992 of 5 stars	$139.80 -0.9%	$150.00 +7.3%	+80.8%	$9.71B	$4.67B	31.76	19,000	News Coverage Positive News Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NGVT) was last updated on 8/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ingevity (NGVT) Competitors